Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
Year: 1998
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
Authors: John C. Morris, Pamela A. Cyrus, John Orazem, Janice Mas, Florian Bieber, Bianca B. Ruzicka, Barbara Gulanski
Institution: Washington University in St. Louis
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bayer Corporation
OpenAlex ID: W2016659621